U.S. biopharmaceutical companies,Year-to-date stock performance
Vir Biotechnology Inc.,279%
Inovio Pharmaceuticals Inc.,278.2%
Moderna Inc.,45.7%
Regeneron Pharmaceuticals Inc.,27.8%
Gilead Science Inc.,17.6%
Sanofi,-4.3%
Johnson & Johnson,-4.8%
Takeda Pharmaceutical Company Ltd.,-8.7%
GlaxoSmithKline,-12.8%
